Meglumine antimoniate intralesional infiltration for localised cutaneous leishmaniasis: a single arm, open label, phase II clinical trial

BACKGROUND Cutaneous leishmaniasis (CL) is a world-wide health problem which currently lacks effective, affordable and easy to use therapy. Recently, the meglumine antimoniate (MA) intralesional infiltration was included among the acceptable therapies for New World leishmaniasis. While this approac...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Dario Brock Ramalho, Rosiana Estéfane da Silva, Maria Camilo Ribeiro de Senna, Hugo Silva Assis Moreira, Mariana Junqueira Pedras, Daniel Moreira de Avelar, Lara Saraiva, Ana Rabello, Gláucia Cota
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Fundação Oswaldo Cruz (FIOCRUZ) 2018-06-01
Edice:	Memorias do Instituto Oswaldo Cruz
Témata:	intralesional infiltration meglumine antimoniate cutaneous leishmaniasis therapy
On-line přístup:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762018000900300&lng=en&tlng=en
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!